FMO5 and cancer: A cascade of cellular O2•− production is shown to be a critical determinant of selective toxicity in aggressive cancer cells [33], which is mediated by the activation of elevated NAD(P)H oxidases [28] and by crosstalk with impaired mitochondrial respiration in cancer cells [13] (Figure 2(a)).